Atrium Therapeutics
Atrium Therapeutics seeks a Manager, Development Sciences Operations to oversee outsourced nonclinical toxicology and pharmacokinetic studies, coordinate CRO activities, and manage the Development Sciences department budget. The role involves cross‑functional collaboration, vendor management, and ensuring timely delivery of study data to support program advancement.
Our vision is to pioneer precision RNA medicines for the heart and profoundly improve the lives of people impacted by cardiac diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Atrium Therapeutics.
Associate Director, Toxicology, Nonclinical Development (Program Toxicologist)
8a7882525b6027b0015b692822e001ab
Sr. Scientist II, Toxicology
oraclecloudinfrastructure
Director of Nonclinical Development, Toxicology
Rhythm Pharmaceuticals
Senior Vice President, Preclinical Toxicology
Nurix
Director of Toxicology
Scholar Rock
Associate Director, Study Operations Manager - Nonclinical Toxicology
Jobgether